05.04.2011 14:00:00

SpringSoft, Real Intent Host Seminar on Advances in System-On-Chip Functional Verification Sign-off

SpringSoft, Inc. (TAIEX: 2473) and Real Intent, Inc. will host a free technical seminar in Silicon Valley on the latest electronic design automation (EDA) developments targeted at accelerating verification sign-off of complex integrated circuit (IC) and system-on-chip (SoC) designs. The agenda features a keynote address by Anant Agrawal, President and CEO of Verayo, Inc., and a founding member of the SPARC processor team at Sun Microsystems.

Technology experts from SpringSoft and Real Intent will present technical sessions on hot topics such as clock domain crossing (CDC) sign-off, verification closure, X-propagation verification, and efficient SystemVerilog testbench development. User case study presentations by YC Wong of Broadcom and Himanshu Bhatnagar of Mindspeed will discuss the verification challenges, tools and methodologies of advanced sign-off flows.

Lunch will be served before the keynote presentation, and two iPads will be given away in a drawing at the conclusion of the seminar. Registration is now open.

When:

   

Thursday, May 5, 2011, 12:00 – 5:00 p.m.

 

Where:

TechMart

 

5201 Great America Parkway

 

Santa Clara, CA 95054

Agenda:

    Keynote Address and Luncheon

Technical Sessions:

  • You Are Doing CDC Verification, But Have You Achieved CDC Sign-off?
  • Getting You Closer to Verification Closure: Techniques for Assessing and Improving Your Verification Environment
  • Don’t Let the X-Bugs Bite: Signing off on X-Verification
  • SystemVerilog Testbench: Innovative Efficiencies for Understanding Your Testbench Behavior

Case Studies:

  • Broadcom
  • Mindspeed
Conclusion and Prize Drawing
Registration:  

For more information or to register online, visit: http://www.springsoft.com/ri-ss-seminar

About SpringSoft

SpringSoft, Inc. is a global supplier of specialized automation technologies that accelerate engineers during the design, verification and debug of complex digital, analog and mixed-signal ICs, ASICs, microprocessors, and SoCs. Its award-winning product portfolio features the Novas™ Verification Enhancement and Laker™ Custom IC Design solutions used by more than 400 of today's leading IDM and fabless semiconductor companies, foundries, and electronic systems OEMs. Headquartered in Hsinchu, Taiwan, SpringSoft is the largest company in Asia specializing in IC design software and a recognized industry leader in customer service with more than 400 employees located in multiple R&D sites and local support offices around the world. For more information, visit www.springsoft.com.

About Real Intent

Real Intent is the leader in automating the intelligence of formal techniques for Advanced Sign-off of electronic designs. Its software dramatically improves functional verification efficiency and design quality for System-on-Chip devices and is used by design and verification teams worldwide. For more information, please visit www.realintent.com.

Novas and Laker are trademarks of SpringSoft, Inc. All other trademarks or registered trademarks are the property of their respective owners.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6672223&lang=en

JETZT DEVISEN-CFDS MIT BIS ZU HEBEL 30 HANDELN
Handeln Sie Devisen-CFDs mit kleinen Spreads. Mit nur 100 € können Sie mit der Wirkung von 3.000 Euro Kapital handeln.
82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren.

Analysen zu Pfizer Inc.mehr Analysen

29.11.24 Pfizer Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14.11.24 Pfizer Neutral UBS AG
01.11.24 Pfizer Neutral UBS AG
30.10.24 Pfizer Buy Goldman Sachs Group Inc.
29.10.24 Pfizer Buy Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Pfizer Inc. 24,77 0,83% Pfizer Inc.

Indizes in diesem Artikel

Dow Jones 44 910,65 0,42%
S&P 500 6 032,38 0,56%
S&P 100 2 902,89 0,68%
NYSE US 100 17 376,20 -0,02%